JENNIFER WARD: Open Payments
NPI 1487258133 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 49 payments from 15 companies in 2025. Trend: 2023 $713 · 2024 $497 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $300 |
| Edwards Lifesciences Corporation | 4 | $239 |
| Boston Scientific Corporation | 2 | $151 |
| Medtronic, Inc. | 1 | $125 |
| Novo Nordisk Inc | 3 | $71 |
| Alnylam Pharmaceuticals Inc. | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Koya Medical, Inc. | 1 | $31 |
| Kestra Medical Technology Services, Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $21 |
Products named: LEQVIO, SAPIEN 3 Ultra RESILIA, WATCHMAN FLX, COREVALVE EVOLUT R, Wegovy, AMVUTTRA, NEXLETOL, KOYA MEDICAL.
Industry payments across AZ — which companies pay providers there.
